 | • レポートコード：MRC2-11QY13549 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はニキビ治療薬のグローバル市場について調査・分析したレポートです。種類別（外用薬、経口薬）市場規模、用途別（炎症性ニキビ、非炎症性ニキビ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ニキビ治療薬の競争状況、市場シェア ・世界のニキビ治療薬市場：種類別市場規模 2015年-2020年（外用薬、経口薬） ・世界のニキビ治療薬市場：種類別市場規模予測 2021年-2026年（外用薬、経口薬） ・世界のニキビ治療薬市場：用途別市場規模 2015年-2020年（炎症性ニキビ、非炎症性ニキビ） ・世界のニキビ治療薬市場：用途別市場規模予測 2021年-2026年（炎症性ニキビ、非炎症性ニキビ） ・北米のニキビ治療薬市場分析：米国、カナダ ・ヨーロッパのニキビ治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのニキビ治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のニキビ治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのニキビ治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Pfizer、Johnson & Johnson、Roche、Teva Pharmaceutical、Bayer、Mylan、Allergan、Bausch Health、Nestle (Galderma)、Cipher Pharmaceuticals、Sun Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin.
US is Expected to Retain Largest Market Share. North America is expected to dominate the market owing to a rising awareness and the growing population of teenagers as well as the growing healthcare expenditure in the region. It is one of the most common disorders in the United States and affects a large section of teenagers and young adults including primarily the female patient’s population. Factors such as lifestyle changes, awareness programs regarding acne, and easy availability of acne treatments drive this market in this region. Apart from this, Asia-Pacific is expected to grow at a higher rate compared to other regions, due to a largely diversified patient pool including a major section of the population in the young adults age-group as well as the rising healthcare infrastructure.
Market Analysis and Insights: Global Acne Therapeutics Market
The global Acne Therapeutics market size is projected to reach US$ 6223.3 million by 2026, from US$ 6000 million in 2020, at a CAGR of 3.4%% during 2021-2026.
Global Acne Therapeutics Scope and Market Size
Acne Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acne Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Pfizer
Johnson & Johnson
Roche
Teva Pharmaceutical
Bayer
Mylan
Allergan
Bausch Health
Nestle (Galderma)
Cipher Pharmaceuticals
Sun Pharmaceutical
Market segment by Type, the product can be split into
Topical Medication
Oral Medication
Market segment by Application, split into
Inflammatory Acne
Non-inflammatory Acne
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acne Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Acne Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Topical Medication
1.4.3 Oral Medication
1.5 Market by Application
1.5.1 Global Acne Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Inflammatory Acne
1.5.3 Non-inflammatory Acne
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acne Therapeutics Market Perspective (2015-2026)
2.2 Global Acne Therapeutics Growth Trends by Regions
2.2.1 Acne Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acne Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Acne Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acne Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Acne Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acne Therapeutics Players by Market Size
3.1.1 Global Top Acne Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Acne Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Acne Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acne Therapeutics Market Concentration Ratio
3.2.1 Global Acne Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acne Therapeutics Revenue in 2019
3.3 Acne Therapeutics Key Players Head office and Area Served
3.4 Key Players Acne Therapeutics Product Solution and Service
3.5 Date of Enter into Acne Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acne Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Acne Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acne Therapeutics Market Size by Application (2015-2020)
5.2 Global Acne Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acne Therapeutics Market Size (2015-2020)
6.2 Acne Therapeutics Key Players in North America (2019-2020)
6.3 North America Acne Therapeutics Market Size by Type (2015-2020)
6.4 North America Acne Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acne Therapeutics Market Size (2015-2020)
7.2 Acne Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Acne Therapeutics Market Size by Type (2015-2020)
7.4 Europe Acne Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Acne Therapeutics Market Size (2015-2020)
8.2 Acne Therapeutics Key Players in China (2019-2020)
8.3 China Acne Therapeutics Market Size by Type (2015-2020)
8.4 China Acne Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acne Therapeutics Market Size (2015-2020)
9.2 Acne Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Acne Therapeutics Market Size by Type (2015-2020)
9.4 Japan Acne Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acne Therapeutics Market Size (2015-2020)
10.2 Acne Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acne Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Acne Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Acne Therapeutics Market Size (2015-2020)
11.2 Acne Therapeutics Key Players in India (2019-2020)
11.3 India Acne Therapeutics Market Size by Type (2015-2020)
11.4 India Acne Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acne Therapeutics Market Size (2015-2020)
12.2 Acne Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Acne Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Acne Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Acne Therapeutics Introduction
13.1.4 GlaxoSmithKline Revenue in Acne Therapeutics Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Acne Therapeutics Introduction
13.2.4 Pfizer Revenue in Acne Therapeutics Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Acne Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Acne Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Acne Therapeutics Introduction
13.4.4 Roche Revenue in Acne Therapeutics Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Details
13.5.2 Teva Pharmaceutical Business Overview
13.5.3 Teva Pharmaceutical Acne Therapeutics Introduction
13.5.4 Teva Pharmaceutical Revenue in Acne Therapeutics Business (2015-2020)
13.5.5 Teva Pharmaceutical Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Acne Therapeutics Introduction
13.6.4 Bayer Revenue in Acne Therapeutics Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Mylan
13.7.1 Mylan Company Details
13.7.2 Mylan Business Overview
13.7.3 Mylan Acne Therapeutics Introduction
13.7.4 Mylan Revenue in Acne Therapeutics Business (2015-2020)
13.7.5 Mylan Recent Development
13.8 Allergan
13.8.1 Allergan Company Details
13.8.2 Allergan Business Overview
13.8.3 Allergan Acne Therapeutics Introduction
13.8.4 Allergan Revenue in Acne Therapeutics Business (2015-2020)
13.8.5 Allergan Recent Development
13.9 Bausch Health
13.9.1 Bausch Health Company Details
13.9.2 Bausch Health Business Overview
13.9.3 Bausch Health Acne Therapeutics Introduction
13.9.4 Bausch Health Revenue in Acne Therapeutics Business (2015-2020)
13.9.5 Bausch Health Recent Development
13.10 Nestle (Galderma)
13.10.1 Nestle (Galderma) Company Details
13.10.2 Nestle (Galderma) Business Overview
13.10.3 Nestle (Galderma) Acne Therapeutics Introduction
13.10.4 Nestle (Galderma) Revenue in Acne Therapeutics Business (2015-2020)
13.10.5 Nestle (Galderma) Recent Development
13.11 Cipher Pharmaceuticals
10.11.1 Cipher Pharmaceuticals Company Details
10.11.2 Cipher Pharmaceuticals Business Overview
10.11.3 Cipher Pharmaceuticals Acne Therapeutics Introduction
10.11.4 Cipher Pharmaceuticals Revenue in Acne Therapeutics Business (2015-2020)
10.11.5 Cipher Pharmaceuticals Recent Development
13.12 Sun Pharmaceutical
10.12.1 Sun Pharmaceutical Company Details
10.12.2 Sun Pharmaceutical Business Overview
10.12.3 Sun Pharmaceutical Acne Therapeutics Introduction
10.12.4 Sun Pharmaceutical Revenue in Acne Therapeutics Business (2015-2020)
10.12.5 Sun Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acne Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Acne Therapeutics Revenue
Table 3. Ranking of Global Top Acne Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acne Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Topical Medication
Table 6. Key Players of Oral Medication
Table 7. Global Acne Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Acne Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Acne Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Acne Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Acne Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Acne Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Acne Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Acne Therapeutics Players
Table 18. Global Acne Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Acne Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Acne Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Therapeutics as of 2019)
Table 21. Global Acne Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acne Therapeutics Product Solution and Service
Table 24. Date of Enter into Acne Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Acne Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Acne Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Acne Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Acne Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Acne Therapeutics Market Share (2019-2020)
Table 34. North America Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Acne Therapeutics Market Share by Type (2015-2020)
Table 36. North America Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Acne Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Acne Therapeutics Market Share (2019-2020)
Table 40. Europe Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Acne Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Acne Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Acne Therapeutics Market Share (2019-2020)
Table 46. China Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Acne Therapeutics Market Share by Type (2015-2020)
Table 48. China Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Acne Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Acne Therapeutics Market Share (2019-2020)
Table 52. Japan Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Acne Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Acne Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Acne Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Acne Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Acne Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Acne Therapeutics Market Share (2019-2020)
Table 64. India Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Acne Therapeutics Market Share by Type (2015-2020)
Table 66. India Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Acne Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Acne Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Acne Therapeutics Market Share (2019-2020)
Table 70. Central & South America Acne Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Acne Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Acne Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Acne Therapeutics Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Product
Table 92. Roche Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 93. Roche Recent Development
Table 94. Teva Pharmaceutical Company Details
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Product
Table 97. Teva Pharmaceutical Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 98. Teva Pharmaceutical Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Product
Table 107. Mylan Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 108. Mylan Recent Development
Table 109. Allergan Business Overview
Table 110. Allergan Product
Table 111. Allergan Company Details
Table 112. Allergan Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 113. Allergan Recent Development
Table 114. Bausch Health Company Details
Table 115. Bausch Health Business Overview
Table 116. Bausch Health Product
Table 117. Bausch Health Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 118. Bausch Health Recent Development
Table 119. Nestle (Galderma) Company Details
Table 120. Nestle (Galderma) Business Overview
Table 121. Nestle (Galderma) Product
Table 122. Nestle (Galderma) Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 123. Nestle (Galderma) Recent Development
Table 124. Cipher Pharmaceuticals Company Details
Table 125. Cipher Pharmaceuticals Business Overview
Table 126. Cipher Pharmaceuticals Product
Table 127. Cipher Pharmaceuticals Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 128. Cipher Pharmaceuticals Recent Development
Table 129. Sun Pharmaceutical Company Details
Table 130. Sun Pharmaceutical Business Overview
Table 131. Sun Pharmaceutical Product
Table 132. Sun Pharmaceutical Revenue in Acne Therapeutics Business (2015-2020) (Million US$)
Table 133. Sun Pharmaceutical Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acne Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Topical Medication Features
Figure 3. Oral Medication Features
Figure 4. Global Acne Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Inflammatory Acne Case Studies
Figure 6. Non-inflammatory Acne Case Studies
Figure 7. Acne Therapeutics Report Years Considered
Figure 8. Global Acne Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Acne Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Acne Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Acne Therapeutics Market Share by Players in 2019
Figure 13. Global Top Acne Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Acne Therapeutics Revenue in 2019
Figure 15. North America Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Acne Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
ニキビ治療の世界市場（～2026年） Acne is considered to be among the topmost prevalent diseases in the world. The inflammatory acne segment is the largest acne type segment in the global acne treatment market. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits.…- ニキビの世界市場（～2026年） Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the facebut can also be a nu…
- 局所用ニキビ治療の世界市場（～2026年） Acne is the most common skin disease and topical treatment can reduce the severity and frequency of acne growth. Market Analysis and Insights: Global Topical Use Acne Treatment Market The global Topical Use Acne Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million …
- ニキビ薬の世界市場（～2026年） Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. It generally affects skin with comparatively high…
- 尋常性ざ瘡の世界市場（～2026年） Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. Acne Vulgaris is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, th…